drugset / Trial / NCT02129179

The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart Failure

NCT02129179

Phase 1 Completed 10 enrolled Papworth Hospital NHS Foundation Trust
NaSingle-groupOpen-labelBasic science

Summary

This study aims to assess the effect of glucagon-like peptide-1 on cardiac output and transpulmonary gradient in patients undergoing right heart catheterisation for clinical reasons.

Timeline

Start
2014-06
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject GLP-1 Peptide Other

Indications